Healthpeak Properties, Inc. (New York Stock Exchange:DOC)
| Market Cap | $13.99B+15.0% |
| Revenue (ttm) | $3.06B+9.4% |
| Net Income | $388.11M+1119.3% |
| EPS | $0.54+1035.9% |
| Shares Out | 689.54M |
| PE Ratio | 37.56 |
| Forward PE | 114.85 |
| Dividend | $1.22(6.01%) |
| Ex-Dividend Date | Dec 18, 2026 |
| Volume | 1,555,333 |
| Open | $20.45 |
| Previous Close | $20.39 |
| Day's Range | $20.05 - $20.49 |
| 52-Week Range | $15.70 - $22.95 |
| Beta | 0.99 |
| Analysts | Hold |
| Price Target | $22.00(+8.46%) |
| Earnings Date | Feb 1, 2027 |
About DOC
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
6 firms rating DOC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 18, 2026Ex-dividend date
- Feb 1, 2027Earnings report
$DOC stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of DOC by members of U.S. Congress
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 8, 2026 |
| Lisa C. McClainHouse / R | Sale$1.00K – $15.00K | Aug 4, 2025 |
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Jun 17, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Apr 1, 2025 |
Recently reported changes in DOC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DOC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DOC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
DOC Revenue by Segment or Geography
| Adjusted NOI - outpatient medical and lab | $325.14M | 23.22% |
| Outpatient medical | $314.75M | 22.48% |
| Senior housing | $268.30M | 19.16% |
| Lab | $223.87M | 15.99% |
| NOI - outpatient medical and lab | $192.70M | 13.76% |
| Gain (loss) upon change of control, net | $46.27M | 3.30% |
| Plus: Adjustments to NOI | $22.24M | 1.59% |
| Other non-reportable revenues | $6.77M | 0.48% |
| Impairments and loan loss reserves, net | $210.00K | 0.01% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New DOC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DOC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DOC
| VNQVanguard Real Estate ETF | $521.35M |
| VTIVanguard Morningstar Total Stock Market ETF | $438.23M |
| VOOVanguard S&P 500 ETF | $361.62M |
| VBVanguard Morningstar Small-Cap ETF | $309.95M |
| RSPInvesco S&P 500 Equal Weight ETF | $203.12M |
| VBRVanguard Morningstar Small-Cap Value ETF | $201.72M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from DOC’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat on FFO and revenue with raised FY2026 guidance offset by analyst price target cut and refinancing concerns.